Pennant Group (PNTG) Stock Price
Pennant Group Price
Revenue has compounded at 17.8% per year over the past 9 years to 947.71 M USD. Earnings per share have grown at 12.8% per year over the last 9 years. Pennant Group's net margin stands at 3.1%, up from 0.6% several years earlier. Analysts set a median price target of 46.00 USD, implying 14.3% above the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Pennant Group stock price
Pennant Group business model & stock analysis
Frequently asked questions about Pennant Group
The business model of Pennant Group Inc revolves around providing healthcare services to patients. As a leading provider of home health, hospice, and senior living services, Pennant Group Inc aims to enhance the quality of life for individuals by delivering personalized care and support. The company focuses on ensuring positive clinical outcomes and nurturing strong patient relationships. Pennant Group Inc continues to innovate and adapt its services to meet the evolving needs of its customers, while maintaining a commitment to compassionate and high-quality care.
Pennant Group Inc is primarily active in the healthcare industry.
The main competitors of Pennant Group Inc in the market include Kindred Healthcare, Amedisys Inc, and LHC Group Inc.
The Pennant Group Inc is a leading provider of healthcare services, focusing on home health, hospice, and senior living. With a rich history spanning several decades, Pennant Group Inc has established itself as a trusted name in the industry. Founded in 2019 and headquartered in Eagle, Idaho, the company has expanded its footprint nationwide, offering personalized care and support to individuals across the United States. Pennant Group Inc has a strong commitment to delivering high-quality services, fostering partnerships with healthcare professionals, and enhancing the well-being of their patients. With a dedicated team and a customer-centric approach, Pennant Group Inc continues to grow and excel in the healthcare sector.
Pennant Group Inc has achieved several significant milestones. The company has successfully expanded its services and geographic presence, establishing itself as a leading provider of home health, hospice, and senior living services. Pennant Group Inc has also demonstrated strong financial performance, with consistent revenue growth and improved margins. The company's solid track record has allowed it to attract and retain a talented team, ensuring the delivery of high-quality care to its patients. Pennant Group Inc continues to innovate and adapt to industry changes, positioning itself for future success and long-term value creation.
Pennant Group Inc is primarily present in the United States. They have an extensive presence throughout the country, offering their services in various states and regions. As a leading company in the healthcare industry, Pennant Group Inc provides high-quality care and services to patients across different states in the US. With a strong commitment to improving patient outcomes and delivering personalized care, Pennant Group Inc continues to expand its reach and impact in the healthcare sector.
Pennant Group Inc represents a strong commitment to providing exceptional healthcare services. With a focus on integrity, compassion, and teamwork, the company strives to improve lives through high-quality care. Pennant Group Inc emphasizes personalized attention, ensuring patients' needs are met with respect and dignity. Their corporate philosophy centers around fostering a supportive and inclusive environment for their employees, allowing them to deliver excellent care. By embracing innovation and clinical expertise, Pennant Group Inc aims to exceed patient expectations and create long-term value for their stakeholders.
Analysts currently set an average price target of 44.67 USD for the Pennant Group stock (median: 46.00 USD), implying +11.0 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Pennant Group stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pennant Group to generate revenue of 1.18 B USD and earnings per share of 1.36 USD.
Converted at the current exchange rate, the Pennant Group share trades at 35.94 EUR (40.26 USD).
The Pennant Group share (PNTG) is listed on 3 stock exchanges, including: NASDAQ (PNTG), Frankfurt (1ZU.F), München (1ZU.MU).
The Pennant Group Inc. is a US-based company that operates in the healthcare sector. The company operates a network of care facilities and offers various services to support patients in their recovery, care, and assistance. In addition to providing care to patients in their homes, the Pennant Group Inc. also offers outpatient care and rehabilitation services, as well as hospice and palliative care. The Pennant Group operates in six different business segments: home care, employee health, hospice care, mobility support, rehab centers, and senior living. Each business segment specializes in meeting the needs of patients in various stages of health. An important aspect of Pennant Group's business model is collaboration with various healthcare facilities and insurance providers to provide seamless care to patients. By working closely with hospitals and rehabilitation clinics, Pennant Group can receive patients in their facilities and then smoothly transition them to outpatient care once their health allows. Another important offering is mobile care services. Medical services are provided through a mobile platform and application, allowing patients to manage their care providers and appointments. The Pennant Group also specializes in training caregivers and offering healthcare staffing services. The company benefits from the demand for qualified professionals in the healthcare industry and provides training and educational facilities to ensure caregivers stay up to date and improve their understanding of the latest medical and health developments. In summary, Pennant Group's business model focuses on a wide range of services that meet the needs of patients in various stages of health. Through collaboration with hospitals and rehabilitation clinics, as well as the use of mobile platforms and training facilities, the company has been able to expand its reach and secure an established marketplace. As the healthcare industry is a growing market segment, Pennant Group is well positioned to further expand its business and meet the demand for high-quality healthcare services.
The expected revenue of Pennant Group is 1.18 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Pennant Group is 48.38 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Pennant Group is currently 29.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pennant Group stock.
The price-to-sales ratio (P/S) of Pennant Group is currently 1.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Pennant Group stock.
The Eulerpool Quality Score for Pennant Group is 5/10.
The ISIN of Pennant Group is US70805E1091. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Pennant Group is A2PRK9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Pennant Group is PNTG. The ticker symbol is used to trade Pennant Group shares on the stock exchange.
Pennant Group stock
Pennant Group Peer Group
Pennant Group Ticker
Pennant Group FIGI
All fundamentals and in-depth analysis of Pennant Group
Our stock analysis for Pennant Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pennant Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.